Effectiveness of an Inactivated SARS-CoV-2 Vaccine

N Engl J Med. 2021 Sep 2;385(10):946-948. doi: 10.1056/NEJMe2111165.

Authors

Annelies Wilder-Smith¹, Kim Mulholland¹

Affiliation

¹ From the Institute of Social and Preventive Medicine, University of Bern, Switzerland (A.W.-S.); Murdoch Children's Research Institute, Melbourne, VIC, Australia (K.M.); and the London School of Hygiene and Tropical Medicine, London (K.M.).

No abstract available

Publication types

Editorial

MeSH terms

COVID-19 / epidemiology
COVID-19 / prevention & control*
COVID-19 Vaccines / immunology*
Chile / epidemiology
Disease Transmission, Infectious / prevention & control
Hospitalization / statistics & numerical data
Humans
Immunogenicity, Vaccine*
Incidence
Mass Vaccination*
Treatment Outcome
Vaccines, Inactivated*

Substances

COVID-19 Vaccines
Vaccines, Inactivated